Navitoclax
Navitoclax
To Order Contact us: caitlyn@ucb-bioproducts.com
) ABT-263 (Navitoclax) |
|||
| A3007-100 | ApexBio | 100 mg | EUR 456 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||
ABT-263 (Navitoclax) |
|||
| A3007-1000 | ApexBio | 1 g | EUR 3298 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||
ABT-263 (Navitoclax) |
|||
| A3007-5 | ApexBio | 5 mg | EUR 108 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||
ABT-263 (Navitoclax) |
|||
| A3007-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 166 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||
ABT-263 (Navitoclax) |
|||
| A3007-50 | ApexBio | 50 mg | EUR 282 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||
ABT-263 (Navitoclax) |
|||
| A3007-S | ApexBio | Evaluation Sample | EUR 81 |
|
Description: ABT-263 is an orally sellecitive inhibitor of B-cell leukemia 2 (Bcl-2) family of proteins with potential antineoplastic activity. ABT-263 is a small molecular with the formula of C47H55ClF3N5O6S3 and Molecular Weight of 974. |
|||